CD4+CD69+FOXP3− Tregs accounted for the vast majority of tumor‐infiltrating Tregs compared with FOXP3+ Tregs and could suppress the CD4+ T‐cell response mainly through mTGF‐β1. This evidence concerns the gene CD69 and neoplasm.